170 related articles for article (PubMed ID: 31933785)
1. A case report on epithelioid inflammatory myofibroblastic sarcoma in the abdominal cavity.
Zhang S; Wang Z
Int J Clin Exp Pathol; 2019; 12(10):3934-3939. PubMed ID: 31933785
[TBL] [Abstract][Full Text] [Related]
2. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
[TBL] [Abstract][Full Text] [Related]
3. Epithelioid Inflammatory Myofibroblastic Sarcoma With Poor Response to Crizotinib: A Case Report.
Aminimoghaddam S; Pourali R
Clin Med Insights Case Rep; 2023; 16():11795476231163954. PubMed ID: 37841512
[TBL] [Abstract][Full Text] [Related]
4. Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring
Wang Z; Geng Y; Yuan LY; Wang MM; Ye CY; Sun L; Dai WP; Zang YS
Front Oncol; 2022; 12():761558. PubMed ID: 35237506
[TBL] [Abstract][Full Text] [Related]
5. ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report.
Xu X; Li H; Peng K; Yu Y; Chen L; Fang Y; Sun Y; Hou Y; Liu T
Oncol Lett; 2019 Feb; 17(2):2370-2376. PubMed ID: 30675302
[TBL] [Abstract][Full Text] [Related]
6. Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib.
Li M; Xing R; Huang J; Shi C; Wei C; Wang H
Front Oncol; 2023; 13():1084456. PubMed ID: 37035183
[TBL] [Abstract][Full Text] [Related]
7. Epithelioid inflammatory myofibroblastic sarcoma of stomach: diagnostic pitfalls and clinical characteristics.
Xu P; Shen P; Jin Y; Wang L; Wu W
Int J Clin Exp Pathol; 2019; 12(5):1738-1744. PubMed ID: 31933992
[TBL] [Abstract][Full Text] [Related]
8. Crizotinib in ALK
Theilen TM; Soerensen J; Bochennek K; Becker M; Schwabe D; Rolle U; Klingebiel T; Lehrnbecher T
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286567
[TBL] [Abstract][Full Text] [Related]
9. Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma.
Jiang Q; Tong HX; Hou YY; Zhang Y; Li JL; Zhou YH; Xu J; Wang JY; Lu WQ
Orphanet J Rare Dis; 2017 May; 12(1):97. PubMed ID: 28535796
[TBL] [Abstract][Full Text] [Related]
10. Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review.
Singh P; Nambirajan A; Gaur MK; Raj R; Kumar S; Malik PS; Jain D
J Pathol Transl Med; 2022 Jul; 56(4):231-237. PubMed ID: 35843628
[TBL] [Abstract][Full Text] [Related]
11. A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib.
Kimbara S; Takeda K; Fukushima H; Inoue T; Okada H; Shibata Y; Katsushima U; Tsuya A; Tokunaga S; Daga H; Okuno T; Inoue T
Jpn J Clin Oncol; 2014 Sep; 44(9):868-71. PubMed ID: 25028698
[TBL] [Abstract][Full Text] [Related]
12. Posttransplant epithelioid inflammatory myofibroblastic sarcoma: A case report.
Garg R; Kaul S; Arora D; Kashyap V
Indian J Pathol Microbiol; 2019; 62(2):303-305. PubMed ID: 30971562
[TBL] [Abstract][Full Text] [Related]
13. Epithelioid inflammatory myofibroblastic sarcoma in abdominal cavity: a case report and review of literature.
Wu H; Meng YH; Lu P; Ning HY; Hong L; Kang XL; Duan MG
Int J Clin Exp Pathol; 2015; 8(4):4213-9. PubMed ID: 26097614
[TBL] [Abstract][Full Text] [Related]
14. Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.
Yu L; Liu J; Lao IW; Luo Z; Wang J
Diagn Pathol; 2016 Jul; 11(1):67. PubMed ID: 27460384
[TBL] [Abstract][Full Text] [Related]
15. Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.
Liu Q; Kan Y; Zhao Y; He H; Kong L
Int J Clin Exp Pathol; 2015; 8(11):15328-32. PubMed ID: 26823889
[TBL] [Abstract][Full Text] [Related]
16. Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review.
Dou W; Guan Y; Liu T; Zheng H; Feng S; Wu Y; Wang X; Liu Z
Front Oncol; 2023; 13():1212529. PubMed ID: 37841422
[TBL] [Abstract][Full Text] [Related]
17. Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case.
Fang H; Langstraat CL; Visscher DW; Folpe AL; Schoolmeester JK
Int J Gynecol Pathol; 2018 Sep; 37(5):468-472. PubMed ID: 28787324
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study.
Liu X; Gong C; Zhang J; Feng W; Guo Y; Sang Y; Wang C; Chen Y; Wang J; Yu L; Zhang X; Luo Z
Cancer Res Treat; 2023 Jul; 55(3):1001-1010. PubMed ID: 36915248
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.
Du X; Gao Y; Zhao H; Li B; Xue W; Wang D
Oncol Lett; 2018 Jun; 15(6):9317-9326. PubMed ID: 29805657
[TBL] [Abstract][Full Text] [Related]
20. Epithelioid Inflammatory Myofibroblastic Sarcoma with Leukemoid Reaction.
Wan YY; Miao CL; Liu SB; Zhang T; Luo CH
J Coll Physicians Surg Pak; 2022 Sep; 32(9):1212-1215. PubMed ID: 36089724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]